CardioGenics has developed a portfolio of patent-protected products focused on improving diagnostic testing sensitivity.
We have developed a novel, proprietary and patent-protected method for controlling the delivery of compounds to a chemical reaction, thus automating their trigger. The delivery, release and activity of chemical compound in a chemical reaction are controlled by a method that employs an electronic signal. When applied to a chemiluminescent reaction, release of the trigger chemical compound initiates the chemical reaction and thus light generation. The result is a highly sensitive testing platform. This technology is deployed in CardioGenics’ POC platform, allowing a much simplified mechanical design.
A portfolio of patent-protected technologies focused on improving testing sensitivity.
For further information contact us